CD38 and triple-A syndrome: In the present study, we found that CD38 deficiency in SMCs markedly inhibited the AngII-induced increase in lumen size and medial thickness, collagen deposition, and the elastin degradation, suggesting that the protection of CD38 deficiency on AngII-induced AAA formation is associated with the inhibition of vascular remodeling.